ExxonMobil (XOM)

Accumulated OCI

-$11.55B

Quarterly · Period ending: · USD

XOM logo

XOM Accumulated OCI

Latest reported-$11.55B
XOM Quarterly Accumulated OCI ($0.00 → -$11.55B)
High-resolution chart · PNG

XOM accumulated oci history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ExxonMobil Accumulated OCI — Quarterly (USD)
Period endingAccumulated OCI (USD)
-11,549,000,000
-11,098,000,000
-10,863,000,000
-12,782,000,000
-12,436,000,000
-14,338,000,000
-14,619,000,000
-11,959,000,000
-13,187,000,000
-13,169,000,000
-11,989,000,000
-13,088,000,000
-12,657,000,000
-13,095,000,000
-13,270,000,000
-17,803,000,000
-15,017,000,000
-12,914,000,000
-13,764,000,000
-16,696,000,000
-15,586,000,000
-16,090,000,000
-16,705,000,000
-20,189,000,000
-21,617,000,000
-24,339,000,000
-19,493,000,000
-19,277,000,000
-18,205,000,000
-18,782,000,000
-19,564,000,000
-18,370,000,000
-18,609,000,000
-16,992,000,000
-16,262,000,000
-16,651,000,000
-18,902,000,000
-20,679,000,000
-22,239,000,000
-20,466,000,000
-20,744,000,000
-20,384,000,000
-23,511,000,000
-24,336,000,000
-21,493,000,000
-22,595,000,000
-18,957,000,000
-12,196,000,000
-9,311,000,000
-11,040,000,000
-10,725,000,000
-13,051,000,000
-14,381,000,000
-12,767,000,000
-12,184,000,000
-9,113,000,000
-10,659,000,000
-7,998,000,000
-9,123,000,000
-5,328,000,000
-2,799,000,000
-3,656,000,000
-4,823,000,000
-4,339,000,000
2,051,000,000
-5,537,000,000
-5,461,000,000
-6,380,000,000
-8,249,000,000
-10,900,000,000
-9,931,000,000
-61,000,000
3,847,000,000
3,504,000,000
1,989,000,000
849,000,000
-1,274,000,000
-2,546,000,000
-2,762,000,000
548,000,000
513,000,000
-882,000,000
-2,545,000,000
-1,628,000,000
-2,054,000,000
-742,000,000
513,000,000
-1,296,000,000
-1,982,000,000
-1,490,000,000
-1,148,000,000
-3,603,000,000
-4,366,000,000
-5,934,000,000
-6,504,000,000
-4,587,000,000
-4,093,000,000
-6,807,000,000
-6,749,000,000
-6,306,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.